Hot Features
Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya vir... Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is headquartered in Melbourne, Australia. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.025 | -14.7058823529 | 0.17 | 0.17 | 0.145 | 2463806 | 0.16099172 | DE |
| 4 | -0.035 | -19.4444444444 | 0.18 | 0.185 | 0.145 | 1418982 | 0.16826706 | DE |
| 12 | -0.105 | -42 | 0.25 | 0.295 | 0.145 | 1730977 | 0.19944145 | DE |
| 26 | -0.2 | -57.9710144928 | 0.345 | 0.37 | 0.145 | 1292114 | 0.24119124 | DE |
| 52 | -0.155 | -51.6666666667 | 0.3 | 0.48 | 0.145 | 1139441 | 0.29186384 | DE |
| 156 | -0.705 | -82.9411764706 | 0.85 | 1.095 | 0.145 | 1047977 | 0.37020044 | DE |
| 260 | -2.005 | -93.2558139535 | 2.15 | 2.69 | 0.145 | 872018 | 0.68595342 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.